The first FDA-approved CGM System that lets you make treatment decisions without pricking your finger.*
The Dexcom G5® Continuous Glucose Monitoring (CGM) System provides real-time glucose readings for patients with type 1 or type 2 diabetes every five minutes. With Dexcom G5 Mobile, dynamic glucose data can be accessed and shared safely and conveniently anywhere, anytime to your smart device.† The Dexcom G5 Mobile - the first CGM system approved for adults and pediatric patients two years of age and older.
*Dexcom CGM-based treatment requires fingersticks for calibration; may result in hypoglycemia if calibration not performed or symptoms/expectations do not match CGM readings.